Pregnant patients with psoriasis hospitalized for delivery have a higher risk for preeclampsia, cardiac arrhythmias and other cardiovascular complications, according to a study. “Of importance for ...

Arcutis Biotherapeutics has a lofty goal for 2025 — and it could help Arcutis stock continue a massive run that helped shares ...

Bristol Myers Squibb Co. forecast 2025 sales and profit below Wall Street’s expectations — a sign that declining sales of ...

Kalm Therapeutics is a biotechnology research company developing a prescription patch treatment for eczema and psoriasis. The ...

The Inflation Reduction Act (IRA), passed in 2022, made changes to the way drugs are covered and reimbursed in Medicare.

On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.

A much touted emerging treatment, red light therapy, lives up to the hype for a lot of health claims, but certainly not ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

Your indoor versus outdoor environment could have an even bigger impact on your eczema symptoms than you realize.

Fred Alger Management, an investment management company, released its “Alger Spectra Fund” fourth quarter 2024 investor letter. A copy of the investor letter can be downloaded here. U.S. equities ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get ...